Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent.
Desborough MJR., Mitchell JL., Whitworth P., Al Juwaiser A., Sage T., Kriek N., Little G., Vaiyapuri S., Gibbins JM., Bye AP.